Lumida
/ODD
⌘K
Oddity Tech Ltd

Oddity Tech Ltd

ODD
$16.33USD↓-0.09%-0.02 today

MARKET CAP

753.0M

P/E (TTM)

12.1x

FWD P/E

14.4x

DAY RANGE

$16 – $17

52W RANGE

$9
$76

AI Summary

Stalk
StalkMedium

ODD is in an early Stage 1 consolidation with repaired EMAs and a Bullish Pivot Point indicating mean-reversion bias, but price is extended above rising 9EMA/21EMA and RSI sits in extreme overbought territory. Medium-term structure favors a bullish bias, yet short-term timing is unfavorable, so execution will be deferred—stalking for a pullback into the rising EMAs and the base resistance-turned-support zone before committing.

  • ↑Q1 2025 revenue grew 25% YOY to $268 M, beating forecasts.
  • ↑Q1 cash $667 M funds up-to-$200 M share repurchase program.
  • ↓Q1 2026 net revenue declined 26% YOY to $45 M, first orders −50%.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Oddity Tech Ltd. (NASDAQ: ODD) operates in the beauty and wellness sector with a direct-to-consumer (DTC) business model. The company has established itself through innovative product offerings and a focus on high-efficacy treatments. Oddity is in a competitive landscape but is striving to leverage technology and improve its customer engagement, particularly through its new telehealth platform, Methodic. As the company navigates challenges related to customer acquisition costs (CPA), it remains committed to enhancing its existing brands—Il Makiage and Spoiled Child—while capitalizing on emerging opportunities in the dermatology and wellness markets.

Bull says

  • ↑Q1 2025 revenue grew 25% YOY to $268 M, beating forecasts.
  • ↑Q1 cash $667 M funds up-to-$200 M share repurchase program.
  • ↑Over 70% of revenue from repeat sales, boosting retention.
  • ↑New Methodic telehealth brand projects ~$25 M in annual revenue.
  • ↑Positive Growth and Liquidity factors support ongoing expansion funding.

Bear says

  • ↓Q1 2026 net revenue declined 26% YOY to $45 M, first orders −50%.
  • ↓Momentum factor score severely negative, indicating weakening stock performance.
  • ↓QS Score −1.11 signals balance-sheet strain; Goldman cuts PT to $8.
  • ↓High customer acquisition costs weigh on margins and user growth.
  • ↓Negative Earnings Yield and Revisions factors point to valuation risks.
  • ↓Adjusted EBITDA loss of $7 M highlights profitability challenges.

Investment themes with ODD

Most Shorted Stocks↑ +0.54%

Stocks with highest short interest

LITE · FSLY · SPHR

Earnings Call · Q1 2025 · Mgmt. Guidance

Updated 06-02-2026bullish

Transcript signals

Bull points

  • gross margin was a nice highlight for us in the quarter, with great execution from our teams across a number of areas. As we look longer term, we've talked about the right kind of run rate for our gross margins to be more in the high 60s kind of range.
  • we set the tone for the full year by ramping up our acquisition spend, which leads to high visibility backlogs of repeat that drives our full year financial results.
  • Net revenue grew 27% to $268 million, exceeding the high end of our guidance for 24% growth to $262 million.

Bear points

  • in 2025 we expect there to be something like a 50 to 100 basis point impact on our gross margin from the flow through of tariffs in 2025.
Read full transcript analysis ›